McKesson Specialty Health Launches Optimization Toolkit for Oncology In-Office Dispensing Program

June 20, 2016

Toolkit adds analytics, pharmacist support and legal guidance, features unavailable with other IOD programs

The Woodlands, Texas (June 20, 2016) — McKesson Specialty Health announced today the enhancement of its widely acclaimed In-Office Dispensing program for oncology practices by launching an Optimization Toolkit to drive improved financial performance and patient care excellence. The McKesson In-Office Dispensing program for oral oncolytics was first launched in 2010 to help oncology practices deliver local, high-quality oral chemotherapy to their patients and increase their revenue. The new Optimization Toolkit adds unique components to the McKesson In-Office Dispensing program, including data analytics and dedicated oncology pharmacy expertise, as well as high touch operational support across marketing, workflow training and legal guidance. These Toolkit products and services help practices take their in-office dispensing business to the next level, maximizing revenue and ensuring therapy adherence and continuity of care in today’s challenging healthcare landscape.

“More than half of the current phase III oncology pipeline is comprised of oral therapies, and the future will bring even more of these innovative treatments to the forefront,” said Randy Hyun, senior vice president and general manager of Provider Solutions for McKesson Specialty Health. “McKesson’s In-Office Dispensing program, along with the Optimization Toolkit, can help practices take advantage of this dramatic increase in oral oncolytics and identify revenue growth opportunities while supporting the delivery of safe, efficient high-quality care for patients.” 

The Optimization Toolkit is the first of its kind in the marketplace, providing several invaluable components to drive financial performance and exceptional care, including:

Data Analytics

  • Diagnostic data analytics that deliver useful, actionable intelligence by analyzing  key metrics to uncover opportunities for business optimization
  • Benchmarking, goal setting and post optimization engagement analytics to measure success

Pharmacy Optimization Team

  • Strategic engagement opportunities with pharmacy experts designed to help practices diagnose opportunities and affect positive change

Operational Support

  • Suite of customizable tools and templates and expert guidance for practices looking to market their services to patients and prescribers
  • Advanced workflow and pharmacy training courses to enable practices to increase efficiency 
  • Exclusive legal platform with guidance on state regulations for physician dispensing and retail pharmacy models

“Supporting practices in optimizing and growing their dispensing programs is an important investment area for McKesson Specialty Health,” said Brandon Tom, senior director of Oral Oncolytic Services for McKesson Specialty Health. “We have helped more than 1,000 physicians implement dispensing capabilities over the last four years, so it’s important that we also focus on ensuring that they continue to evolve their programs to thrive in a rapidly changing environment. Establishing a network of practices as a best-in-class site of care for oral oncolytics is not only critical in providing the best patient care possible, but also in creating collaborative relationships with the payer and manufacturer community.”

In-office dispensing of oral medications delivers key benefits to both cancer patients and practices by empowering seamless, uninterrupted quality care, enhancing practice revenue while providing a better patient experience, and supporting optimal outcomes. Comprehensive, in-house medication management enables improved medication compliance and continuity of care through better control of patient IV and oral therapy. Additionally, it is more convenient for patients, as it reduces the need to send them to an outside pharmacy or hospital for prescribed medications.

“In the face of rising drug costs and decreasing reimbursements, community oncology practices need to consider innovative solutions to ensure practice growth and survival. Our in-office dispensing solution can help practices to not only expand their services and grow revenue, but also prepare for the many changes that will impact oncology – and most importantly, patient care – in the future,” Hyun concluded.

About McKesson Specialty Health

McKesson Specialty Health, a division of McKesson Corporation, empowers the community patient care delivery system by helping community practices advance the science, technology and quality of care. Through innovative clinical, research, business and operational solutions, facilitated by integrated technology systems, we focus on improving the financial health of our customers so they may provide the best care to their patients. For more information, visit

Public Relations Contact